Citation: | Liu Yin, Zhao Bin, Xie Yu-sai, Yang Tao. Screening and bioinformatics analysis of IgA nephropathy gene based upon GEO database[J]. Journal of Clinical Nephrology, 2021, 21(3): 194-198. DOI: 10.3969/j.issn.1671-2390.m20-132 |
[1] |
Rodrigues JC,Haas M,Reich HN.IgA Nephropathy[J].Clinical journal of the American Society of Nephrology:CJASN,2017,12(4):677-86.DOI: 10.2215/cjn.07420716.
|
[2] |
Donadio JV,Grande JP.IgA nephropathy[J].The New England journal of medicine,2002,347(10):738-48.DOI: 10.1056/NEJMra020109.
|
[3] |
Wyatt RJ,Julian BA.IgA nephropathy[J].The New England journal of medicine,2013,368(25):2402-14.DOI: 10.1056/NEJMra1206793.
|
[4] |
Cui HX,Zhang YX,Zhang QJ,et al.A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma[J].Cancer Med,2017,6(12):2932-2941.DOI: 10.1002/cam4.1180.
|
[5] |
Tian W,Liu J,Pei BJ,et al.Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer[J].Oncol Rep,2016,35(4):2171-2176.DOI: 10.3892/or.2016.4561.
|
[6] |
Zhou LT,Qiu S,Lv LL,et al.Integrative bioinformatics analysis provides insight into the molecular mechanisms of chronic kidney disease[J].Kidney Blood Press Res,2018,43(2):568-581.DOI: 10.1159/000488830.
|
[7] |
Shu BY,Fang Y,He WC,et al.Identification of macrophage-related candidate genes in lupus nephritis using bioinformatics analysis[J].Cell Signal,2018,46:43-51.DOI: 10.1016/j.cellsig.2018.02.006.
|
[8] |
Grayson PC,Eddy S,Taroni JN,et al.Metabolic pathways and immunometabolism in rare kidney diseases[J].Ann Rheum Dis,2018,77(8):1226-1233.DOI: 10.1136/annrheumdis-2017-212935.
|
[9] |
Liu PD,Lassén E,Nair V,et al.Transcriptomic and proteomic profiling provides insight into mesangial cell function in IgA nephropathy[J].J Am Soc Nephrol,2017,28(10):2961-2972.DOI: 10.1681/ASN.2016101103.
|
[10] |
Guo FF,Zhang W,Su J,et al.Prediction of drug positioning for Quan-du-Zhong capsules against hypertensive nephropathy based on the robustness of disease network[J].Front Pharmacol,2019,10:49.DOI: 10.3389/fphar.2019.00049.
|
[11] |
Diboun I,Wernisch L,Orengo CA,et al.Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma[J].BMC Genomics,2006,7:252.DOI: 10.1186/1471-2164-7-252.
|
[12] |
Huang DW,Sherman BT,Tan QN,et al.The DAVID Gene Functional Classification Tool:a novel biological module-centric algorithm to functionally analyze large gene lists[J].Genome Biol,2007,8(9):R183.DOI: 10.1186/gb-2007-8-9-r183.
|
[13] |
Szklarczyk D,Morris JH,Cook H,et al.The STRING database in 2017:quality-controlled protein-protein association networks,made broadly accessible[J].Nucleic Acids Res,2017,45(D1):D362-D368.DOI: 10.1093/nar/gkw937.
|
[14] |
Kohl M,Wiese S,Warscheid B.Cytoscape:software for visualization and analysis of biological networks[J].Methods Mol Biol,2011,696:291-303.DOI: 10.1007/978-1-60761-987-1_18.
|
[15] |
Chin CH,Chen SH,Wu HH,et al.cytoHubba:identifying hub objects and sub-networks from complex interactome[J].BMC Syst Biol,2014,8(Suppl 4):S11.DOI: 10.1186/1752-0509-8-S4-S11.
|
[16] |
Ebefors K,Liu PD,Lassén E,et al.Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1[J].BMC Nephrol,2016,17:40.DOI: 10.1186/s12882-016-0251-5.
|
[17] |
Cederholm B,Wieslander J,Bygren P,et al.Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy[J].Proc Natl Acad Sci USA,1988,85(13):4865-4868.DOI: 10.1073/pnas.85.13.4865.
|
[18] |
Misaki T,Naka,Kuroda K,et al.Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients[J].Clin Exp Nephrol,2015,19(5):844-850.DOI: 10.1007/s10157-014-1072-0.
|
[19] |
Kawai Y,Masutani K,Torisu K,et al.Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy:a possible role of albumin as an antioxidant agent[J/OL].PLoS One,2018,13(5):e0196655.DOI: 10.1371/journal.pone.0196655.
|
[20] |
Mori Y,Masuda T,Kosugi T,et al.The clinical relevance of plasma CD147/basigin in biopsy-proven kidney diseases[J].Clin Exp Nephrol,2018,22(4):815-824.DOI: 10.1007/s10157-017-1518-2.
|
[21] |
Liao YX,Zhang ZP,Zhao J,et al.Effects of fibronectin 1 on cell proliferation,senescence and apoptosis of human glioma cells through the PI3K/AKT signaling pathway[J].Cell Physiol Biochem,2018,48(3):1382-1396.DOI: 10.1159/000492096.
|
[22] |
Shui HA,Ka SM,Lin JC,et al.Fibronectin in blood invokes the development of focal segmental glomerulosclerosis in mouse model[J].Nephrol Dial Transplant,2006,21(7):1794-1802.DOI: 10.1093/ndt/gfl113.
|
[23] |
Altunkova I,Minkova V,Belovezhdov N.Role of fibronectin in immune glomerulonephritis[J].Nephron,1993,63(4):438-444.DOI: 10.1159/000187249.
|
[24] |
Coppo R,Camilla R,Amore A,et al.Oxidative stress in IgA nephropathy[J].Nephron Clin Pract,2010,116(3):c196-c198,discussionc199.DOI: 10.1159/000317199.
|
[25] |
Remuzzi G,Bertani T.Pathophysiology of progressive nephropathies[J].N Engl J Med,1998,339(20):1448-1456.DOI: 10.1056/NEJM199811123392007.
|
[26] |
Eddy AA.Proteinuria and interstitial injury[J].Nephrol Dial Transplant,2004,19(2):277-281.DOI: 10.1093/ndt/gfg533.
|